(1)
Machado, P. M.; Barohn, R. J.; McDermott, M. P.; Sundgreen, C.; Blaettler, T.; Hanna, M. G.; Dimachkie, M. Design and Rationale for a Randomized, Double-Blind, Placebo-Controlled Phase 2 3 Trial of Oral Arimoclomol in Inclusion Body Myositis. rrnmf 2024, 5 (2). https://doi.org/10.17161/rrnmf.v4i5.16244.